169 related articles for article (PubMed ID: 30081854)
1. RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
Redmond HP; Neary PM; Jinih M; O'Connell E; Foley N; Pfirrmann RW; Wang JH; O'Leary DP
BMC Cancer; 2018 Aug; 18(1):794. PubMed ID: 30081854
[TBL] [Abstract][Full Text] [Related]
2. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
3. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Opitz I; Van der Veen H; Witte N; Braumann C; Mueller JM; Jacobi CA
Eur Surg Res; 2007; 39(3):129-35. PubMed ID: 17337889
[TBL] [Abstract][Full Text] [Related]
4. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
[TBL] [Abstract][Full Text] [Related]
5. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
Jiménez Hernández M; Soriano A; Filella X; Calvo M; Coll E; Rebled JM; Poch E; Graterol F; Compte MT; Maduell F; Fontsere N
J Vasc Access; 2021 May; 22(3):370-379. PubMed ID: 32691665
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.
Wouters Y; Theilla M; Singer P; Tribler S; Jeppesen PB; Pironi L; Vinter-Jensen L; Rasmussen HH; Rahman F; Wanten GJA
Aliment Pharmacol Ther; 2018 Aug; 48(4):410-422. PubMed ID: 29978597
[TBL] [Abstract][Full Text] [Related]
7. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
[TBL] [Abstract][Full Text] [Related]
8. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
Handrup MM; Møller JK; Schrøder H
Pediatr Blood Cancer; 2013 Aug; 60(8):1292-8. PubMed ID: 23417891
[TBL] [Abstract][Full Text] [Related]
9. The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.
Opitz I; van der Veen HC; Braumann C; Ablassmaier B; Führer K; Jacobi CA
Surg Endosc; 2003 Jul; 17(7):1098-104. PubMed ID: 12712383
[TBL] [Abstract][Full Text] [Related]
10. Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
Braumann C; Menenakos C; Atanassov V; Pfirrmann RW; Guenther N; Jacobi CA
Eur Surg Res; 2008; 40(4):341-6. PubMed ID: 18303270
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
[TBL] [Abstract][Full Text] [Related]
12. Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats.
Braumann C; Ordemann J; Wildbrett P; Jacobi CA
Clin Exp Metastasis; 2000; 18(7):547-52. PubMed ID: 11688959
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine in the prevention and therapy of lung metastases.
Hoksch B; Rufer B; Gazdhar A; Bilici M; Beshay M; Gugger M; Schmid RA
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1058-63. PubMed ID: 19850492
[TBL] [Abstract][Full Text] [Related]
14. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial.
Xie J; Hu Q; Ma J; Huang Q; Pei F
Bone Joint J; 2017 Nov; 99-B(11):1442-1449. PubMed ID: 29092982
[TBL] [Abstract][Full Text] [Related]
15. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
Nestler G; Schulz HU; Schubert D; Krüger S; Lippert H; Pross M
Surg Endosc; 2005 Feb; 19(2):280-4. PubMed ID: 15870965
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat.
Jacobi CA; Peter FJ; Wenger FA; Ordemann J; Müller JM
Dig Surg; 1999; 16(5):393-9. PubMed ID: 10567800
[TBL] [Abstract][Full Text] [Related]
18. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
[TBL] [Abstract][Full Text] [Related]
19. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
[TBL] [Abstract][Full Text] [Related]
20. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Betjes MG; van Agteren M
Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]